Phase 3 trial of Imeglimin

Trial Profile

Phase 3 trial of Imeglimin

Phase of Trial: Phase III

Latest Information Update: 16 Feb 2018

At a glance

  • Drugs Imeglimin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Feb 2018 New trial record
    • 14 Feb 2018 According to a Roivant Sciences media release, this trial is anticipated to begin in 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top